AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Byline: GLORIA LAU
Digene Corp
Gaithersburg, Md.
digene.com
For Digene Corp., the year brought good news. Its potential market of $60 million blossomed into $500 million.
Here's how it happened: This summer the company won Food and Drug Administration approval to market its test for the human papillomavirus, or HPV, for use with every Pap smear requested by women over 30.
Before this, Digene could market the test for use as a follow-on exam for women whose Pap smear results came back inconclusive -- only 6% of all Paps.